Telmisartan
Telmisartan is a pharmaceutical drug with 127 clinical trials. Currently 4 active trials ongoing. Historical success rate of 92.0%.
Success Metrics
Based on 104 completed trials
Phase Distribution
Phase Distribution
30
Early Stage
12
Mid Stage
61
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
91.2%
104 of 114 finished
8.8%
10 ended early
4
trials recruiting
127
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes
Study of TelmisartanFor the Prevention of Acute GVHD Post Allogeneic Hematopoietic Stem Cell Transplantation
Telmisartan for Prevention of Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients
Telmisartan in Combination With Cytotoxic Regimens in Platinum-Resistant Ovarian Cancer
Edmond J. Safra Accelerating Clinical Trials in Parkinson's Disease: A Multiarm Multi-stage Platform Trial
Clinical Trials (127)
Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes
Study of TelmisartanFor the Prevention of Acute GVHD Post Allogeneic Hematopoietic Stem Cell Transplantation
Telmisartan for Prevention of Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients
Telmisartan in Combination With Cytotoxic Regimens in Platinum-Resistant Ovarian Cancer
Edmond J. Safra Accelerating Clinical Trials in Parkinson's Disease: A Multiarm Multi-stage Platform Trial
Telmisartan in Prostate Cancer
INTERVENCION Trial
Telmisartan vs. Perindopril in Mild-Moderate Alzheimer's Disease Patients
SAFE-CRP: Structural Alterations and Function of Endothelium in Cardiovascular Risk Patients
Efficacy and Safety of Telmisartan Compared With Losartan
A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Compare Telmisartan (MICARDIS) 80 mg Versus Losartan (COZAAR) 100 mg, in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy (AMADEO Study)
PROBE Investigation of the Safety & Efficacy of Telmisartan (Micardis®) vs Ramipril (Altace®) Using ABPM in HTN
Telmisartan in Respiratory Failure Due to COVID-19
Replication of the ONTARGET Antihypertensive Trial in Healthcare Claims Data
Replication of the TRANSCEND Antihypertensive Trial in Healthcare Claims Data
Telmisartan Versus Enalapril in Heart Failure With Reduced Ejection Fraction Patients With Moderately Impaired Kidney Functions
A Clinical Trial to Evaluate the Blood Pressure Control of Telmisartan or Losartan in Essential Hypertensive Patients With Metabolic Syndrome
Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan and Other ARBs on Outcomes of Coronavirus Infection?
Telmisartan Plus Exercise to Improve Functioning in Peripheral Artery Disease
Efficacy of Hydroxychloroquine, Telmisartan and Azithromycin on the Survival of Hospitalized Elderly Patients With COVID-19
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 127